I'm not sure if this will get past the moderator. This is not an endorsement of CYDY, although several on this board own it. However, of interest is the "Breakthrough Therapy Designation" or BTD. I don't know if this is a goal of NGIO or not, as we have not had an update for some time. This is the first I've read of BTD and revenue potential. Hopefully, the moderator agrees that this article has some application here. If not, go to Seeking Alpha.

https://seekingalpha.com/article/4314267-real...esignation